HEMLIBRA® recommended dosage

The recommended dose is 3 mg/kg by subcutaneous injection once weekly for the first 4 weeks, followed by one of the maintenance dose options.

Note: Same weight-based dosage for all age ranges.
  • The prophylactic use of FVIII products may be continued during the first week of HEMLIBRA prophylaxis
  • Discontinue the prophylactic use of BPAs the day before starting HEMLIBRA prophylaxis

The selection of a maintenance dose should be based on healthcare provider preference with consideration of regimens that may increase patient adherence

Missed dose

If a dose of HEMLIBRA is not administered on the scheduled day, administer as soon as possible before the day of the next scheduled dose, and then resume usual dosing schedule. Do not administer two doses on the same day to make up for a missed dose.

Dosage forms & strengths

HEMLIBRA is available as a colorless to slightly yellow solution in single-dose vials (1 per carton).

  • 30 mg/mL
  • 60 mg/0.4 mL
  • 105 mg/0.7 mL
  • 150 mg/mL

Refer to the HEMLIBRA Instructions for Use for handling instructions when combining vials. Do not combine HEMLIBRA vials of different concentrations in a single injection.

Dosing Guide

Download the HEMLIBRA Dosing Guide

Dosing Calculator 

Help calculate the dosage for your HEMLIBRA patient